Sport & Auto
- About Future
- Digital Future
- Cookies Policy
- Terms & Conditions
- Investor Relations
- Contact Future
All the best bikes, gear and other tech from the Tour de France
The bike of the tallest man in the Tour de France
Mechanics equip riders with special bikes, tubulars and modifications
IAM Cycling rider's bike radiates orange
While legally not a violation of the anti-doping code, Danish rider Michael Rasmussen was found to...
While legally not a violation of the anti-doping code, Danish rider Michael Rasmussen was found to have taken Dynepo in the 2007 Tour de France. Dynepo is an EPO product based on human cells. Samples from this year's Tour were analysed in the French anti-doping lab in Châtenay-Malabry, and its technicians have alerted the International Cycling Union (UCI) of the findings, French paper L'Equipe reported in its Friday edition.
Dynepo was found in a urine test of Rasmussen. Rasmussen had not been found positive during the Tour, but was kicked out by his team Rabobank, following his whereabouts affair.
For about a year the French lab has detected Dynepo, all in all about ten cases so far, according to Pierre Bordry, the president of the French Anti-Doping Agency. But none of the cases could have been declared as a positive finding, as the WADA criteria of positivity of a test are not yet adapted to the advances in the pharmaceutical market.